Delivery Order SPE2DB20D3103-SPE2DB23FN6E5

Award Date 6/6/23
Potential Completion Date 6/7/23
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,776.00 fixed-price delivery order contract is for 4566893159 LAMOTRIGINE ODT 100 MG TABLET 30S, with a performance period ending on January 13, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a $12,990.43 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a variety of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Through this IDC, Amerisourcebergen supplies specialty, brand name, generic,...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,415.65 firm fixed-price delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,392.44. The contract is for pharmaceutical and medical supply products to support the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,438.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is part of a larger single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,859.76 delivery order contract has a firm fixed-price pricing type and will run through October 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,127.60, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is for pharmaceutical and medical supply distribution services provided by AmerisourceBergen Drug Corp to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $37,297.59, is a Firm Fixed Price Delivery Order that runs through November 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA to supply a comprehensive range of medical products, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,199 firm fixed-price delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which runs through November 2026. This IDC enables the government to efficiently procure a comprehensive range of pharmaceutical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FN6E5
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,140.95 Firm Fixed Price Delivery Order is for the supply of Lamotrigine ER 300 mg tablets. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which expires in November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 11:25 AM